NLM Digital Collections

Disease-modifying therapies for relapsing-remitting and primary-progressive multiple sclerosis: effectiveness and value : final evidence report

Collection:
Health Policy and Services Research
Contributor(s):
California Technology Assessment Forum, issuing body.
Institute for Clinical and Economic Review, issuing body.
Publication:
Boston, MA : Institute for Clinical and Economic Review, March 6, 2017
Language(s):
English
Format:
Text
Subject(s):
Comparative Effectiveness Research
Multiple Sclerosis, Chronic Progressive -- drug therapy
Multiple Sclerosis, Relapsing-Remitting -- drug therapy
Antirheumatic Agents -- adverse effects
Antirheumatic Agents -- economics
Antirheumatic Agents -- therapeutic use
Benchmarking
Cost-Benefit Analysis
Immunosuppressive Agents -- adverse effects
Immunosuppressive Agents -- economics
Immunosuppressive Agents -- therapeutic use
Insurance Coverage
Randomized Controlled Trials as Topic
Treatment Outcome
Humans
United States
Genre(s):
Technical Report
Copyright:
Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information)
Extent:
1 online resource (1 PDF file (iv, ES29, 217 pages))
Illustrations:
Illustrations
NLM Unique ID:
101704699 (See catalog record)
Permanent Link:
http://resource.nlm.nih.gov/101704699